首页> 美国卫生研究院文献>Cardiology and Therapy >Efficacy and Safety of Novel Oral Anticoagulants for Atrial Fibrillation Ablation: An Updated Meta-Analysis

【2h】

Efficacy and Safety of Novel Oral Anticoagulants for Atrial Fibrillation Ablation: An Updated Meta-Analysis

机译：新型口服抗凝剂对房颤消融的疗效和安全性：最新的荟萃分析

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

IntroductionNovel oral anticoagulants (NOACs) have been approved for prevention of stroke and systemic embolism in patients with non-valvular atrial fibrillation (NVAF). A large number of patients are on NOACs when they present for AF ablation. We intended to evaluate the safety and efficacy of NOACs for AF ablation during the periprocedural period by performing a meta-analysis of trials comparing NOACs with warfarin.

机译：简介新型口服抗凝剂（NOAC）已被批准用于预防非瓣膜性房颤（NVAF）患者的中风和全身性栓塞。许多患者出现房颤消融时使用NOAC。我们打算通过对NOAC与华法林进行比较的试验的荟萃分析，评估围手术期NOAC进行房颤消融的安全性和有效性。

著录项

期刊名称 Cardiology and Therapy
作者
Ajay Vallakati; Abhishek Sharma; Mohammed Madmani; Madhu Reddy; Arun Kanmanthareddy; Sampath Gunda; Dhanunjaya Lakkireddy; William R. Lewis;
展开▼
作者单位

展开▼
年(卷),期 2016(5),1
年度 2016
页码 85–100
总页数 16
原文格式 PDF
正文语种
中图分类心血管疾病;
关键词
Ablation Atrial fibrillation Bleeding Complications Meta-analysis Novel oral anticoagulants (NOACs) Thromboembolism;

机译：消融;房颤;出血;并发症;Meta分析;新型口服抗凝剂（NOAC）;血栓栓塞;

相似文献

外文文献
中文文献
专利

1. Efficacy and Safety of Novel Oral Anticoagulants for Atrial Fibrillation Ablation: An Updated Meta-Analysis [J] . Ajay Vallakati, Abhishek Sharma, Mohammed Madmani, Cardiology and therapy. . 2016,第1期

机译：新型口服抗凝剂对房颤消融的疗效和安全性：最新的荟萃分析
2. Meta-analysis of safety and efficacy of oral anticoagulants in patients requiring catheter ablation for atrial fibrillation [J] . Hammad Rahman, Safi U. Khan, Michael DePersis, Cardiovascular revascularization medicine: including molecular interventions . 2019,第2期

机译：荟萃分析，需要导管消融心房颤动的患者口腔抗凝血剂的安全性和疗效
3. Meta-analysis of safety and efficacy of oral anticoagulants in patients requiring catheter ablation for atrial fibrillation [J] . Rahman Hammad, Khan Safi U., DePersis Michael, Nature reviews neuroscience . 2019,第2期

机译：在需要导管消融心房颤动的患者中口腔抗凝血剂的安全性和疗效的荟萃分析
4. What Is the Best Practical Scheme for Initiating Oral Anticoagulant Treatment in Outpatients with Atrial Fibrillation? [C] . R. CAZZIN, P. SERRA, C. FUSILLI International Workshop on Cardiac Arrhythmias . 2004

机译：在心房颤动的门诊患者中启动口服抗凝血治疗的最佳实用方案是什么？
5. Differences in activated clotting time among uninterrupted anticoagulants during the periprocedural period of atrial fibrillation ablation [D] . Nagao Tomoyuki, 長尾知行 2019

机译：房颤消融围手术期不间断抗凝药激活凝血时间的差异
6. Efficacy and Safety of Non-Vitamin K Antagonist Oral Anticoagulants versus Vitamin K Antagonist Oral Anticoagulants in Patients Undergoing Radiofrequency Catheter Ablation of Atrial Fibrillation: A Meta-Analysis [O] . Giuseppe Santarpia, Salvatore De Rosa, Alberto Polimeni, -1

机译：非维生素K拮抗剂口服抗凝剂和维生素K拮抗剂口服抗凝剂在房颤射频导管消融患者中的疗效和安全性：一项荟萃分析
7. Efficacy and Safety of Novel Oral Anticoagulants for Atrial Fibrillation Ablation: An Updated Meta-Analysis [O] . Ajay Vallakati, Abhishek Sharma, Mohammed Madmani, 2016

机译：新型口服抗凝剂对房颤消融的疗效和安全性：最新的荟萃分析

Efficacy and Safety of Novel Oral Anticoagulants for Atrial Fibrillation Ablation: An Updated Meta-Analysis

摘要

著录项

相似文献

相关主题

期刊订阅